{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T05:29:01Z","timestamp":1695706141230},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 72-year-old man with a family history of prostate cancer and initial diagnosis of favorable intermediate risk prostate cancer via biopsy in 2017 elected for active surveillance. Two years later, he underwent prostate biopsy showing intermediate-risk cT1c Nx Mx lesion with Gleason score 3 + 4 = 7 (5 core positive). Transrectal ultrasound showed a prostate volume 28 mL, and the prostate-specific antigen was 8.1. Patient elected to proceed with combination radiation therapy and androgen deprivation therapy.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003094","type":"journal-article","created":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T02:30:35Z","timestamp":1589423435000},"page":"e334-e335","source":"Crossref","is-referenced-by-count":0,"title":["Focal 18F-NaF PET Prostate Activity in the Setting of Prostate Adenocarcinoma"],"prefix":"10.1097","volume":"45","author":[{"given":"Jason","family":"Chiang","sequence":"first","affiliation":[{"name":"Department of Radiology, UCLA Ronald Reagan Hospital, Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan P.","family":"Gershenson","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiarash","family":"Vahidi","sequence":"additional","affiliation":[{"name":"Radiology, VA Greater Los Angeles HealthCare System, California."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gholam R.","family":"Berenji","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,5,12]]},"reference":[{"key":"bib1-20230925","first-page":"272","article-title":"Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET\/CT and comparison between 18F-fluoride PET and 18F-fluoride PET\/CT","volume":"45","year":"2004","journal-title":"J Nucl Med"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1016\/j.crad.2016.05.001","article-title":"Evidence-based indications for the use of PET-CT in the UK 2016","volume":"71","year":"2016","journal-title":"Clin Radiol"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/RLU.0b013e318217af49","article-title":"Extraosseus uptake of F-18 fluoride in the primary malignancy and cerebral metastasis in a case of non\u2013small-cell lung cancer","volume":"36","year":"2011","journal-title":"Clin Nucl Med"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1007\/s12350-018-1325-5","article-title":"18F-sodium fluoride positron emission tomography assessed microcalcifications in culprit and non-culprit human carotid plaques","volume":"26","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(13)61754-7","article-title":"18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial","volume":"383","year":"2014","journal-title":"Lancet"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"e484","DOI":"10.1097\/RLU.0000000000002317","article-title":"18F-NaF PET\/CT in prostatic calculi","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate Imaging Reporting and Data System version 2.1: 2019 update of Prostate Imaging Reporting and Data System version 2","volume":"76","year":"2019","journal-title":"Eur Urol"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13000-016-0478-2","article-title":"Grading of prostatic adenocarcinoma: current state and prognostic implications","volume":"11","year":"2016","journal-title":"Diagn Pathol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T06:10:02Z","timestamp":1695622202000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,12]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003094","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,12]]}}}